Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control

(2014) R. Glynne-Jones et al.   ANNALS OF ONCOLOGY

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial

(2014) Yong Sang Hong et al.   LANCET ONCOLOGY

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study

(2014) Jean-François Bosset et al.   LANCET ONCOLOGY

No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT)

(2014) Aldo Sainato et al.   RADIOTHERAPY AND ONCOLOGY

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) B. Glimelius et al.   ANNALS OF ONCOLOGY

Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years

(2012) Rolf Sauer et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

(2012) Claus Rödel et al.   LANCET ONCOLOGY

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

(2011) Willem van Gijn et al.   LANCET ONCOLOGY

Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials

(2010) K. Bujko et al.   ANNALS OF ONCOLOGY

Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006

(2010) M.A.G. Elferink et al.   EUROPEAN JOURNAL OF CANCER

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

An interim analysis of recruitment to the COLOFOL trial

(2008) P. Wille-Jørgensen et al.   Colorectal Disease